Sep 06, 2023 / 03:00PM GMT
Alvira Macanovic - Ventripoint Diagnostics Ltd. - President & CEO
Good morning, everyone. I want to thank everyone for attending Ventripoint's Q2 2023 corporate update.
Before I start, just for clarity, the purpose of this meeting is to discuss the Q2 financials as well as to discuss some of our sales and marketing -- to give you an update on our sales and marketing efforts. If there's any questions related to the stock, I'd ask that you table those for now. I'm happy -- and our IR team is happy to address that at another time. I would just like to stay focused for this call.
Forward-looking statements. I always like to, at the beginning of -- at the end of every quarter, to remind our team here at Ventripoint and as well as all of our stakeholders, including our shareholders, of the mission and the vision for Ventripoint going forward. Our mission has always been to improve the lives of patients, and that continues.
We want to be able to provide clinicians with the tools that they need to deliver patient care, improve patient care experiences and outcomes. We aim to become
Q2 2023 VentriPoint Diagnostics Ltd Earnings Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers